Document is current
Any future updates will be listed below
-
Authors
De Lazzari, Nico https://orcid.org/0000-0002-0216-8232
Götte, Miriam https://orcid.org/0000-0003-0841-8738
Kasper, Stefan
Meier, Eileen
Schuler, Martin
Pogorzelski, Michael
Siveke, Jens T. https://orcid.org/0000-0002-8772-4778
Tewes, Mitra https://orcid.org/0000-0001-8868-8329
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 30 November 2023
Accepted: 10 June 2024
First Online: 15 June 2024
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Patients and/or the public were not involved in the design, or conduct, or reporting of this research.
: J.T.S. receives honoraria as consultant or for continuing medical education presentations from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Immunocore, MSD Sharp Dohme, Novartis, Roche/Genentech, and Servier. His institution receives research funding from Abalos Therapeutics, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eisbach Bio, and Roche/Genentech; he holds ownership in FAPI Holding (<3%); all outside the submitted work.S.K. received honoraria from Merck Serono, MSD, Novartis, BMS, Amgen, Roche, Sanofi-Aventis, Servier, Incyte and Lilly; research funding from Merck Serono, Lilly, BMS, Roche.The other authors declare that they have no competing interests.
